Your competitors have ads like this too.
ViralMojo finds the ads printing money in your niche and runs this exact teardown on them: hooks named, structures mapped, claims checked.
Tear down my competitorsSee this run on your own brand — free.
Drop your product URL and an AI analyst reads your site, mines what your customers actually say, and pulls your closest competitor's longest-running ads. Live, in about ten minutes.
Run my free teardownProof delivered before a single word. With no text and no branding, the photo reads as organic history content and buys the long copy a read; because it looks like a primary source, it converts the 1976 story from claim into apparent record.
“Why morning joint stiffness is a sign that your cells are…” names the exact symptom the audience woke up to this morning, then cuts off mid-sentence so the Learn More button is what completes the thought. The curiosity gap does the CTA's work.
“On a Pacific farming island in 1976, a 94-year-old Okinawan man with zero joint pain pulled a visiting Japanese gerontologist aside…” stacks hyper-specifics (year, age, place, profession) to borrow documentary credibility, and opens a one-sentence-secret loop the reader can only close by continuing.
Nine beats in the order the reader meets them. The landing page never mentions Okinawa; it restarts the same pitch under a doctor byline. Each beat carries the move you can reuse.
Buried discovery loreAd copy · Intrigue
Frames the mechanism as overlooked knowledge rather than a new invention, which both explains why the reader has never heard of it and pre-positions mainstream medicine as forty years behind.
“The gerontologist wrote it down in a field notebook, filed it under longevity observations, and the page sat in an academic journal almost nobody read.”
Steal itExplain her ignorance without insulting her: point to [a real, linkable source outside her feed] — obscure is fine, checkable is the line. A field notebook nobody can open is a flag, not a hook.
Specialist track villainAd copy + LP · Disqualify
Walks the reader down the exact escalator she is already on (Advil, Tylenol, PT, injections, surgery) and brands every rung as masking, so all conventional next steps are eliminated before the product appears. The LP re-runs the same "treatment plan" and adds a profit motive to it.
“→ When the injections stop working, the conversation becomes about surgery.”
Steal itWalk her down [the exact treatment escalator she is already on] and brand every rung as masking, so the conventional next steps are gone before you appear.
Bricklayer mechanismAd copy · Reframe
Converts joint pain from irreversible mechanical wear into a fixable fuel-supply problem through a manual-labor metaphor tuned to the audience; "everyone blames the wall" indicts every wear-and-tear treatment in one image.
“It's like a crew of bricklayers staring at a pile of bricks in the yard, with no lunch and no power tools. The wall is crumbling, and everyone blames the wall.”
Steal itExplain the mechanism with [one household metaphor] tuned to her world, and make the metaphor indict every rival treatment in the same image.
Symptom mirrorAd copy + LP · Qualify
Behavioral micro-tells let the reader self-diagnose into the story without being told she is the target; the LP repeats the same tells (handrails, chair arms, stairs), so the click lands on recognition.
“Morning stiffness that takes an hour to loosen up. Next-day soreness from what used to be a regular walk. Reaching for the chair arm before standing.”
Steal itMirror [the behavioral micro-tells] rather than the diagnosis, so she self-selects instead of being told she is the target.
Borrowed trial proofAd copy · Prove
Three uncited study summaries with percentages, trial comparisons, and multi-week timelines add clinical texture at the exact moment the story pivots from anecdote to mechanism: precise enough to sound checked, vague enough to be uncheckable.
“Peer-reviewed research now confirms the three-part cellular signal.”
Steal itAdd the clinical texture at the moment the story turns into a mechanism, not before. That pivot is the only place it is needed.
Three-ingredient lockAd copy · Monopolize
Defines the solution as an all-or-nothing trio, which retroactively explains every supplement the reader has already tried as an incomplete signal and disqualifies cheaper single-ingredient competitors in advance.
“NR fuels the workers. Resveratrol flips the switch that puts them to work. Quercetin clears the debris.”
Steal itDefine the fix as an all-or-nothing combination only you carry. Every single-ingredient thing she has tried becomes an incomplete signal.
Outcome snapshot reelAd copy · Future-pace
Results are cast as modest, measurable befores-and-afters that mirror the earlier symptom list one-for-one, so the restraint reads as honesty, and the closing image of squatting to pull a weed loops back to the farmer in the creative.
“→ Morning stiffness shrinking from an hour to twenty minutes”
Steal itKeep the before-and-afters modest and mirrored to the symptom list. Restraint is what reads as honesty.
Named disease coinageLP · Diagnose
Invents an official-sounding diagnosis for the reader's vague ache, converting undifferentiated pain into a named condition that only this page's product is positioned to address.
“This condition, which I call Cellular Repair Deficiency (CRD), is the hidden driver behind so much age-related joint pain.”
Steal itName the vague ache on the landing page in [the words she already uses for it] — a named experience can still have exactly one answer. Coining a fake diagnosis with initials is the flag below, not the move.
Stacked scarcity closeAd copy + LP · Close
Supply pressure is seeded in the ad before the click, then escalated on the LP into sell-out deadlines and months-long restock threats, so urgency rather than the offer itself drives checkout.
“They have sold out before. If you click through and the page is empty, that's just how it is. See it in stock? Grab it now.”
Steal itSeed the supply pressure in the ad and escalate it after the click, so urgency rather than the offer drives checkout.
⚠ Copy the structure, not the claims
- The ad's own logic breaks at the checkout. “All three have to be present, at the same time, at the right doses. Miss any one and the signal doesn't fire.” But the landing page it clicks to sells the product on NR and resveratrol alone and never mentions quercetin.
- The doctor byline sits on a persona network. “Hello, I'm Dr. John Anderson, a clinical researcher…”, from an operation that also fronts the same product through a "Chad Thompson" persona and a "Chronic Pain Support Group" page, on a page whose own footer admits “THIS IS AN ADVERTISEMENT AND NOT AN ACTUAL NEWS ARTICLE”.
- “new research from Harvard Medical School is revealing the real culprit...” An institutional name-drop with no study cited.
- “Stanford University researchers confirmed that NR... repair[s] the damaged DNA in your joints.” An unnamed-study attribution carrying a repair-of-damaged-DNA disease claim.
- “Absolutely no side effects” An absolute safety claim that no supplement can substantiate.
- “With 16 clinical studies backing their work, they've helped over 90,000 people…” Evidence and scale claims with no studies listed and no verifiable customer base.
- The two guarantees contradict each other. The ad closes on a 90-day every-dollar-back guarantee; the LP grants “You're Welcome to Test Vasozi NAD+ for 30 Days”. At least one is false.
- “We Might Sell Out By Tomorrow... Or Maybe Even Today” Evergreen manufactured urgency on a funnel whose ad has run continuously for 129 days.
- The price can't decide what it is. “only £59 per bottle”, restated elsewhere on the same page as “Just $79.”, “$39 per bottle”, “£24 per bottle”, and “£17 per bottle”. Contradictory anchors in two currencies, consistent with a re-skinned template.
- Amazon review furniture on a Shopify page. “Robert M. Reviewed in the United States on July 09, 2024 Verified Purchase”, on the brand's own store, which elsewhere states the product is not sold on Amazon.
Ad copy▾
On a Pacific farming island in 1976, a 94-year-old Okinawan man with zero joint pain pulled a visiting Japanese gerontologist aside to explain why — and what he said in one sentence took Western researchers forty years to verify.
The gerontologist wrote it down in a field notebook, filed it under longevity observations, and the page sat in an academic journal almost nobody read.
Meanwhile, stateside, a generation of people in their 60s were being told joint wear was just what getting older looked like and to take Tylenol.
The farmer's sentence explained something about their joints none of their specialists had a framework for.
And the reason it took the West forty years to catch up isn't what you'd guess.
The page sat in an old gerontology journal for almost forty years.
The 1976 field study was run by a Japanese gerontologist traveling through the Ryukyu Islands, cataloguing an unusual population of elders who had somehow skipped what the West was already calling "the inevitable joint wear of getting old." His notes were clinical and cautious — the way academics write when what they're seeing doesn't match the textbook.
Men in their 80s squatting in rice paddies for hours. Women in their 90s tending gardens and climbing the steps to the village shrine. A near-absence of joint replacements across the island. Farmers moving the way Western bodies stopped moving by 55.
And on one page, he wrote down something a 94-year-old farmer told him outside a paddy, leaning on a wooden handle, rolling his shoulders like they were ten years old.
The farmer said it in one sentence. Nobody in Western medicine picked it up for forty years.
Because stateside, the whole joint pain story was heading somewhere else. The system had pattern-matched the ache to inflammation and built an answer around it.
→ First you take Advil.
→ Your stomach starts hurting, so you switch to Tylenol.
→ Your specialist sends you out for a round of physical therapy that leaves you worse than you started.
→ Your specialist mentions injections.
→ When the injections stop working, the conversation becomes about surgery.
Meanwhile, 7,000 miles away, a man in his mid-90s was squatting in a paddy with joints that had never seen a single one of those steps.
And the reason wasn't genetics. Not a secret diet. Not clean mountain air or anything else the brochures eventually sold. Those were the easy answers Western researchers reached for when they couldn't explain the pattern.
So the data sat. In a language only a few people read. While a generation of Americans were told their joints were doing what aging does. While specialists shrugged and said "lose weight, take Tylenol." While the drug industry built a giant market around masking a signal nobody explained.
Until recently.
A handful of independent researchers went back to that old field work, cross-referenced it with the cellular biology that caught up in the 2010s, and realized what the farmer had described.
The answer wasn't in the rice paddy. It was inside his cells.
Every joint in your body is lined with cartilage. Cartilage is mostly collagen — a repair material your body is supposed to build and rebuild throughout your life. Most people think of collagen as the cartilage itself. It isn't. It's the brick. The real workers are tiny cells jammed into the cartilage whose only job is to lay that brick down and pull the worn-out material out.
Those cells run on a specific cellular fuel. Your body makes it. Your body uses it up. By age 50, the average Western person is running on roughly half what they carried at 25.
It's like a crew of bricklayers staring at a pile of bricks in the yard, with no lunch and no power tools. The wall is crumbling, and everyone blames the wall.
When that cellular fuel drops, the repair cells crawl, then stall, then shut down entirely. Inflammation builds because the cleanup crew runs on the same fuel. Damaged cells that should get pulled out just sit there, pumping inflammatory signals into the tissue.
The ache you feel getting out of a chair isn't cartilage grinding away in some mechanical way. It's a repair crew running on a fuel tank that ran dry about a decade ago.
Here's what that looks like in a Western body: Morning stiffness that takes an hour to loosen up. Next-day soreness from what used to be a regular walk. Reaching for the chair arm before standing. A folder of specialist visits, pills, and injections that were supposed to fix it.
In an Okinawan 94-year-old: none of the above. Not because his cartilage is different. Because his fuel is different.
Remember the bricklayers with no fuel? The Okinawan diet and daily life have, completely by accident, been feeding those cellular workers exactly what they need for decades. Bitter melon. Sweet potato leaves. Fermented foods. Near-constant low-grade movement. The plant ingredients that happen to fire up the repair enzymes in joint cells.
None of it was designed as a joint approach. It was just how they lived.
What modern cellular research finally worked out is that the signal those foods send is reproducible. Not mystical. Not racial. Not regional. It's three ingredients the body uses to keep cellular fuel topped up and the repair crew working.
What the farmer told the gerontologist, translated out of plain farmer-voice, was roughly this: my body still makes what it needs to fix itself.
That was the sentence. That was what sat in a journal for forty years.
Western medicine at the time had no model for a joint that fixes itself. They only had a model for a joint that wears out and gets replaced. So they wrote it off as diet. As genetics. As luck. And the drug industry built a giant market on the assumption the farmer was wrong.
Peer-reviewed research now confirms the three-part cellular signal.
The NAD precursor — the direct fuel the repair cells burn — drops key inflammatory markers 20 to 30 percent in older adults in as little as three weeks.
The second one — from grape skin and a specific Asian root, the same stuff the Okinawan diet is packed with — beat standard knee pain care in a trial, cutting both inflammation and cartilage loss at once. Standard anti-inflammatories can't do both.
And a third plant ingredient in onions and apples clears out damaged cells that keep pumping inflammation into the tissue. In a multi-week trial, a daily dose knocked down morning stiffness and soreness in people with inflammatory joint pain.
The farmer was right. Back then, Western medicine didn't have the framework to hear him.
Here's the catch: You can't move to Okinawa, squat in a rice paddy for thirty years, and eat the way a 94-year-old farmer ate for a lifetime. And the Western diet doesn't deliver any of those three ingredients at the levels the cellular research shows are needed.
One of the researchers who dug back into that old field work figured there must be a way to port this over. One question wouldn't leave him alone... How do you port the Okinawan cellular signal into a Western day?
The answer turned out to be simpler than anyone expected. The signal is chemical. It doesn't require a paddy or a genealogy. It requires three specific ingredients — in the right amounts, together.
Here's what those researchers cracked — what Okinawan farmers never had to figure out because their life was already doing it for them:
The cellular repair signal in a joint doesn't come from ONE ingredient. It comes from THREE.
NR — the direct NAD precursor — feeds the cellular fuel every repair cell in your joints runs on.
Resveratrol — the enzyme activator — hits the same pathway the Okinawan diet activates through bitter melon and sweet potato leaves.
Quercetin — the piece almost nobody outside lab circles knows about — clears out the damaged, worn-out cells that sit in your joints pumping inflammation into the tissue forever.
NR fuels the workers. Resveratrol flips the switch that puts them to work. Quercetin clears the debris.
And here's what the cellular data showed about incomplete versions of the signal: All three have to be present, at the same time, at the right doses. Miss any one and the signal doesn't fire. NR alone is fuel with no switch flipped. Resveratrol alone is a switch with no fuel. Quercetin alone is a clean site with no fueled crew — still a crumbling wall.
It's like handing a beat-up crew a pallet of bricks and no power. The materials are there. The crew can't use them.
That's why millions run the specialist playbook for years — the pills, the injections, the surgery conversation — and end up worse than they started. The whole track was built around inflammation. None of it ever sent the actual repair signal.
Years into the work, a team finally nailed it... A complete cellular joint supplement with ALL THREE ingredients at the studied doses.
That's how Vasozi NAD was built.
It's turned things around for thousands of people. They refuse to go back because of results like...
→ Morning stiffness shrinking from an hour to twenty minutes
→ The ache after sitting easing by week three or four
→ Walks that took two days to recover from stopping at one
→ Getting up out of a chair without the hand on the armrest
→ Gardening Saturday without paying for it Sunday and Monday
→ Inflammatory markers falling on the labs
→ Less reliance on the Advil bottle
→ Catching yourself squatting to pull a weed the way you did at 40
The answer to joint breakdown was never injections or surgery. It was the cellular signal the Okinawan farmers had been running on for a lifetime. Delivered through a simple daily capsule that fills in what a Western life doesn't.
Take a couple of capsules a day. The whole routine takes about 10 seconds. Your joint cells get the same three-part fuel an Okinawan 80-year-old has been running on since before you were born. The repair crew comes back online. Morning stiffness starts shrinking. The walks stop costing you two days.
And when you take it consistently — the way the cellular research shows the signal actually works — it keeps working.
https://vasozi.com/pages/a1
But a warning... The specialist track isn't going to offer you this. The shelves at your specialist's office are still built around inflammation — pills first, injections second, surgery third. None of them fire the three-part cellular signal the Okinawan body has been running on for generations. That whole track was built in a decade before Western medicine had the framework for cellular fuel. It's the same old playbook — knock the inflammation down, send you home, bet on you not asking why your joints aren't actually repairing.
That's what makes Vasozi NAD different. It's built around all THREE ingredients at the studied doses — matching the amounts run in the peer-reviewed research. It's the cellular signal, delivered whole. This isn't an inflammation mask. It's the real signal.
Here's the deal... Right now, Vasozi is running real savings for new customers, backed by a 90-day guarantee. Run it for a full 90 days — roughly how long the cellular research shows the signal needs to reach baseline in a body that's been running low for a decade. If you don't notice your morning stiffness shrinking, your post-walk recovery shortening, and the ache after sitting easing off — you get every dollar back. No questions.
But fair warning: Vasozi runs the studied ingredients at the studied doses, so they can't churn out bottles the way the cheap single-ingredient brands do. They have sold out before. If you click through and the page is empty, that's just how it is. See it in stock? Grab it now.
In 1976, a 94-year-old Okinawan farmer told a visiting gerontologist one sentence about why his body still fixed itself. No injections. No surgery. No pill bottle. Just the cellular signal his life had been delivering for nine decades. His people had been running on it across generations. Western medicine shrugged and called it genetics. Now, at last, you can run on the same signal. And this round, it's not one ingredient. It's the COMPLETE three-part cellular signal. Studied doses. The shortest path back to the cellular state an Okinawan body maintains on its own.
Tap the link below before they sell through again.
https://vasozi.com/pages/a1